This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Blood Cancer (leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple Myeloma) Treatment Market

Market Insights on Blood Cancer (leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple Myeloma) Treatment covering sales outlook, demand forecast & up-to-date key trends

Blood Cancer (leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple Myeloma) Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Blood Cancer (leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple Myeloma) Treatment Market: Global Industry Analysis and Opportunity Assessment 2016-2026 Overview

Blood cancer is a general term used for the cancers that affect blood, bone marrow or lymphatic system. Most of these cancers start in bone marrow where blood cells (RBC, WBC and platelets) are produced from bone marrow stem cells.

In cancerous condition, differentiation of bone marrow stem cells is interrupted to produce abnormal blood cells which hamper the normal functioning of the blood. There are 4 types of blood cancers such as leukemia, Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and multiple myeloma.

Blood cancers develop due to combination of genetic and environmental factors including but not limited to exposure to ionizing radiation, benzene and other petrochemicals, prior chemotherapy, smoking etc.

Plenty of chemotherapeutic agents are available commercially for the treatment of blood cancer such as Leukeran, Gleevec, Cytarine, Neosar, Oncotrex etc. Several new drugs for blood cancer treatment are in clinical trials such as Panobinostat (Phase 2), Bortezomib (phase 4), Oncofetal Ag (phase 1), Volasertib (phase 2) which are likely to launch in next 5-10 years.

Blood Cancer Treatment Market: Drivers and Restraints

High incidence rate of blood cancers in US (leukemia-13.0, NHL-19.8, HL-2.7, myeloma-6.7 cases per 100,000 population in 2014) is the major driver for the growth of blood cancer treatment market in US.  Advancement in technology, personalized medicine, cost effective treatment procedures are few other factors predicted to keep up the growth of global blood cancer treatment market.

However, divergent nature of blood cancers and increasing stringency in the regulatory requirements are some of the major restraints limiting the growth of global blood cancer treatment market.

Customize this Report

Let us know your requirement to get
100% FREE customization

Blood Cancer Treatment Market: Overview

Due of the availability of variety of chemotherapeutic agents for the blood cancer treatment, market for chemotherapeutic agents is expected to hold a greater share in global blood cancer treatment market. Innovative blood cancer treatment procedures are expected to launch into the market in the forecast period.

This will also help to increase the market volume. However, expiry of some of the commonly used drugs such as Erbitux (2014), Rituxan (2019), Gleevec (2015), Herceptin (2023) is anticipated to uplift the generic cancer market within the forecast period. Monoclonal antibodies and other immunological treatments are generally known for their lesser side effects and better efficacy.

Few biological agents like Peg interferone α-2b and Drotrecogine α are already launched into the US market which are expected to generate the remarkable revenue.

Blood Cancer Treatment Market: Regional Overview

Geographically, the global blood cancer treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.North America takes the largest share of global blood cancer treatment market followed by Europe.

The global blood cancer treatment market is expected to grow in future due to increasing investment by multinational companies in cancer research.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Blood Cancer Treatment Market: Key Players

Roche group is one of the leading provider of blood cancer treatment drugs. Some of the key players in blood cancer treatment market are Novartis Pharmaceuticals, Merc & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Johnson & Johnson Pvt. Ltd., Celgen Corporation, Amgen Inc., Teva pharmaceutical Industries Ltd., Bayer AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd. To name a few.

The report covers exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Blood Cancer Treatment Market: Segmentation

The global blood cancer treatment market has been classified on the basis of application, end use and geography.

Based on application, the global blood canner treatment market is divided into following:

  • Biological/immunotherapy
  • Chemotherapy
  • Radiation therapy
  • Targeted therapy
  • Stem cell transplantation

Based on end user type, the global blood canner treatment market is divided into following:

  • Hospitals
  • Clinics
  • Cancer rehabilitation centers

Table of Content

NA

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

NA

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Blood Cancer (leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple Myeloma) Treatment Market